4D Molecular Therapeutics (FDMT) Q4 2024 Earnings

13NovConfirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-0.79
-0.74
-0.68
-0.63

Details

Expected EPS
-0.6759
Actual EPS
-0.79
Surprise EPS
-0.11
Surprise Percent
+16.88%

Description

4D Molecular Therapeutics (FDMT) has reported earnings of -0.79 per share for Q4 2024.

0 Comments

Share your thoughts